NNVC Stock Summary and Trading Ideas (Nanoviricides | AMEX:NNVC)

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Nanoviricides trades on the AMEX stock market under the symbol NNVC.

As of September 8, 2026, NNVC stock price declined to $1.08 with 242,870 million shares trading.

NNVC has a beta of 2.10, meaning it tends to be more sensitive to market movements. NNVC has a correlation of 0.10 to the broad based SPY ETF.

NNVC has a market cap of $27.57 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NNVC traded as high as $3.59 and as low as $.85.

The top ETF exchange traded funds that NNVC belongs to (by Net Assets): VTI, VXF, BUSM.

NNVC has underperformed the market in the last year with a price return of -21.5% while the SPY ETF gained +19.2%. NNVC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.0% and -18.8%, respectively, while the SPY returned +1.4% and 0.0%, respectively.

NNVC support price is $1.08 and resistance is $1.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNVC shares will trade within this expected range on the day.